These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12818925)

  • 1. Kasabach-Merritt syndrome and interferon alpha: still a controversial issue.
    Biban P
    Arch Dis Child; 2003 Jul; 88(7):645-6. PubMed ID: 12818925
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment with interferon alfa in infiltrating angiolipoma: a case presenting with Kasabach-Merritt syndrome.
    Akyüz C; Emir S; Büyükpamukçu M; Büyükpamukçu N; Cağlar M; Kale G; Calişkan U
    Arch Dis Child; 2003 Jan; 88(1):67-8. PubMed ID: 12495967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon alpha-2a therapy of consumptive coagulopathy in Kasabach-Merritt syndrome.
    Klein C; Hauser M; Hadorn HB
    Eur J Pediatr; 1992 Dec; 151(12):919. PubMed ID: 1473549
    [No Abstract]   [Full Text] [Related]  

  • 4. Case report: Kasabach-Merritt syndrome: a review of the therapeutic options and a case report of successful treatment with radiotherapy and interferon alpha.
    Hesselmann S; Micke O; Marquardt T; Baas S; Bramswig JH; Harms E; Willich N
    Br J Radiol; 2002 Feb; 75(890):180-4. PubMed ID: 11893644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The interferon alfa-2a treatment of the severe form of the Kasabach-Merritt syndrome with neonatal onset].
    González de Dios J; Moya Benavent M; Herranz Sánchez Y; Juste Ruiz M; González Montero R
    An Esp Pediatr; 1996 Feb; 44(2):179-83. PubMed ID: 8830584
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of Kasabach-Merritt syndrome with vincristine and diagnosis of the hemangioma using three-dimensional imaging.
    Hara K; Yoshida T; Kajiume T; Ohno N; Kawaguchi H; Kobayashi M
    Pediatr Hematol Oncol; 2009; 26(5):375-80. PubMed ID: 19579084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Giant cavernous haemangioma with Kasabach-Merritt syndrome: a case report and review.
    Frevel T; Rabe H; Uckert F; Harms E
    Eur J Pediatr; 2002 May; 161(5):243-6. PubMed ID: 12012216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of Kasabach-Merritt syndrome with pentoxifylline.
    de Prost Y; Teillac D; Bodemer C; Enjolras O; Nihoul-Fekete C; de Prost D
    J Am Acad Dermatol; 1991 Nov; 25(5 Pt 1):854-5. PubMed ID: 1802912
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful interferon therapy in a neonate with life-threatening Kasabach-Merritt syndrome.
    Nako Y; Fukushima N; Igarashi T; Hoshino M; Sugiyama M; Tomomasa T; Morikawa A
    J Perinatol; 1997; 17(3):244-7. PubMed ID: 9210084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of interferon alfa-2a for life-threatening hemangiomas.
    MacArthur CJ; Senders CW; Katz J
    Arch Otolaryngol Head Neck Surg; 1995 Jun; 121(6):690-3. PubMed ID: 7772325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of recombinant activated factor VII during major surgery in a child with Kasabach-Merritt syndrome.
    Janic D; Brasanac D; Krstovski N; Dokmanovic L; Lazic J; Krstic Z
    Paediatr Anaesth; 2009 Feb; 19(2):177-9. PubMed ID: 19207911
    [No Abstract]   [Full Text] [Related]  

  • 12. Kasabach-Merritt syndrome: dangers of interferon and successful treatment with pentoxifylline.
    de la Hunt MN
    J Pediatr Surg; 2006 Jan; 41(1):e29-31. PubMed ID: 16410085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon alpha-2a therapy for disseminated intravascular coagulation in a patient with blue rubber bleb nevus syndrome. A case report.
    Kunishige M; Azuma H; Masuda K; Shigekiyo T; Arii Y; Kawai H; Saito S
    Angiology; 1997 Mar; 48(3):273-7. PubMed ID: 9071205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of retroperitoneal infantile hemangioendothelioma with Kasabach-Merritt syndrome using steroid, alpha-interferon, and vincristine.
    Yoon HS; Lee JH; Moon HN; Seo JJ; Im HJ; Goo HW
    J Pediatr Hematol Oncol; 2009 Dec; 31(12):952-4. PubMed ID: 19875968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tranexamic acid in the treatment of Kasabach-Merritt syndrome in infants.
    Hanna BD; Bernstein M
    Am J Pediatr Hematol Oncol; 1989; 11(2):191-5. PubMed ID: 2751074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spastic diplegia and interferon.
    Deb G; Jenkner A; Donfrancesco A
    J Pediatr; 1999 Mar; 134(3):382. PubMed ID: 10064684
    [No Abstract]   [Full Text] [Related]  

  • 17. Kasabach-merritt phenomenon: case series and retrospective review of the mayo clinic experience.
    Rodriguez V; Lee A; Witman PM; Anderson PA
    J Pediatr Hematol Oncol; 2009 Jul; 31(7):522-6. PubMed ID: 19564750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brachial plexus paralysis due to giant cavernous hemangioma with Kasabach-Merritt syndrome: successful management with interferon alpha.
    Peker E; Kirimi E; Tuncer O; Ceylan A; Oner AF
    Platelets; 2009 Dec; 20(8):603-5. PubMed ID: 19929246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment.
    Hermans DJ; van Beynum IM; van der Vijver RJ; Kool LJ; de Blaauw I; van der Vleuten CJ
    J Pediatr Hematol Oncol; 2011 May; 33(4):e171-3. PubMed ID: 21516018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cavernous haemangioma with Kasabach-Merritt syndrome: treatment with alpha-interferon.
    Ettlinger JJ; Fleming PJ; Joffe HS; Kennedy CT
    J R Soc Med; 1996 Jan; 89(1):55P-6P. PubMed ID: 8709089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.